Amylyx Pharmaceuticals Valuation Multiples

Amylyx Pharmaceuticals Overview

About Amylyx Pharmaceuticals

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

Founded

2014

HQ

Employees

123

Website

amylyx.com

Sectors

BiopharmaceuticalsBioTech

Financials (LTM)

Revenue: —

EBITDA: ($152M)

EV

$2B

Valuation Multiples

Multiples.vc

Start free trial

Amylyx Pharmaceuticals Financials

Amylyx Pharmaceuticals reported last 12-month revenue of — and negative EBITDA of ($152M).

In the same LTM period, Amylyx Pharmaceuticals generated — in gross profit, ($152M) in EBITDA losses, and had net loss of ($147M).

Amylyx Pharmaceuticals P&L

In the most recent fiscal year, Amylyx Pharmaceuticals reported revenue of — and EBITDA of ($153M).

Amylyx Pharmaceuticals expects next 12-month revenue of XXX and NTM EBITDA of XXX

Amylyx Pharmaceuticals Stock Performance

Amylyx Pharmaceuticals has current market cap of $2B, and enterprise value of $2B.

Amylyx Pharmaceuticals' stock price is $17.32.

Amylyx Pharmaceuticals Valuation Multiples

Amylyx Pharmaceuticals trades at (10.5x) EV/EBITDA.

Amylyx Pharmaceuticals Financial Valuation Multiples

As of April 11, 2026, Amylyx Pharmaceuticals has market cap of $2B and EV of $2B.

Equity research analysts estimate Amylyx Pharmaceuticals' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Amylyx Pharmaceuticals has a P/E ratio of (13.0x).

Amylyx Pharmaceuticals Margins & Growth Rates

Amylyx Pharmaceuticals' revenue in the last fiscal year declined by (100%).

Amylyx Pharmaceuticals' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $1.2M for the same period.

Amylyx Pharmaceuticals Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Amylyx Pharmaceuticals M&A Activity

Amylyx Pharmaceuticals acquired XXX companies to date.

Last acquisition by Amylyx Pharmaceuticals was on XXXXXXXX, XXXXX. Amylyx Pharmaceuticals acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Amylyx Pharmaceuticals Investment Activity

Amylyx Pharmaceuticals invested in XXX companies to date.

Amylyx Pharmaceuticals made its latest investment on XXXXXXXX, XXXXX. Amylyx Pharmaceuticals invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).